Skip to main content
. 2019 Oct 23;10:1267. doi: 10.3389/fphar.2019.01267

Figure 3.

Figure 3

Measurement of neuroendocrine factors after 28 days and 60 days of drug administration. Sham, sham group; Model, model group; Fosinopril, fosinopril group; BXYS (0.4g/kg), Buxin Yishen 0.4 g/kg treated group; BXYS (0.8 g/kg), Buxin Yishen 0.8 g/kg treated group. *P < 0.05, **P < 0.01 vs. sham group. #P < 0.05, ##P < 0.01 vs. model group. +P < 0.05, ++P < 0.01 vs. fosinopril group. (A) Serum concentration of angiotensin II (Ang II) after 28 days. (B) Serum concentration of blood urea nitrogen (BUN) after 28 days. (C) Serum concentration of cyclic guanosine monophosphate (cGMP) after 28 days. (D) Serum creatinine (Scr) after 28 days. (E) Serum concentration of Ang II after 60 days. (F) Serum concentration of C reaction protein (CRP) after 60 days. (G) Serum concentration of BUN after 60 days. (H) Serum concentration of brain natriuretic peptide (BNP) after 60 days. (I) Serum concentration of Scr after 60 days.